In a groundbreaking effort to revolutionize the treatment of heart rhythm disorders, the University of Miami Miller School of Medicine is leading the charge in personalizing patient care. The cardiac electrophysiology group at the institution is pioneering innovative research and treatment strategies for patients with abnormal heart rhythms, particularly atrial fibrillation.
Under the leadership of Dr. Jeffrey Goldberger, the team is making significant strides in understanding atrial fibrillation through advanced methods like catheter ablation. Despite the procedure’s stagnant success rate of 60%, Dr. Goldberger advocates for a more personalized approach to treatment, tailoring strategies based on genetics, age, body composition, and other factors.
Innovative Research and Personalized Care
Dr. Goldberger’s research emphasizes the importance of moving beyond a one-size-fits-all approach. His team utilizes cutting-edge technologies, including artificial intelligence and genetic testing, alongside lifestyle interventions. This holistic approach aims to enhance patient outcomes and pave the way for future breakthroughs in cardiac care.
Dr. Raul Mitrani, a key collaborator, highlights the team’s dedication to personalizing medicine for a broad range of patients. The group operates one of Florida’s only comprehensive risk factor management centers for atrial fibrillation. They offer customized treatment plans, addressing factors such as weight, blood pressure, and sleep apnea, in conjunction with medical interventions.
Research Beyond Borders
The group’s commitment to advancing cardiac care is evident in its participation in several federally funded research projects. Among these is the Liraglutide Effect on Atrial Fibrillation (LEAF) study, which explores the impact of weight-loss drugs on treatment outcomes. The findings suggest a potential doubling of success rates for catheter ablation when combined with adjunctive strategies.
Other notable projects include the OMICS study, which investigates the role of epicardial adipose tissue in atrial fibrillation risk, and the development of 4D Flow MRI technology to better assess stroke risk.
Future Directions
Dr. Goldberger acknowledges the progress made but emphasizes the need for continued innovation. “There have been many real improvements in our approach to atrial fibrillation, but we still have a long, long way to go to get to optimal treatment,” he stated in the original article. The team’s focus remains on identifying gaps and areas for impactful advancements in cardiac care.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Commercial real estate is entering a decade of major transformation driven by interest rate pressures, evolving work culture, rapid proptech innovation, and growing demand for AI-focused infrastructure. While the global CRE market is projected to reach $133.5 trillion by 2028, rising rates, shifting office demand, and increasing sustainability requirements are reshaping how professionals invest, manage, and develop properties. By 2030, the biggest opportunities will center on mixed‑use conversions, data center growth, premium office spaces, and ESG‑driven upgrades.
The National Association of Realtors’ landmark antitrust settlement is transforming how real estate agents negotiate compensation, work with buyers, and handle transparency in transactions. With MLS‑posted buyer‑broker commissions eliminated and written buyer agreements now required, both consumers and professionals are navigating a new, more transparent landscape. While commission levels have only dipped slightly, the real shift is in how openly compensation is discussed and negotiated—creating new challenges and opportunities for agents who adapt quickly.
Artificial intelligence is no longer a novelty in real estate — 2025 marks its breakthrough year as a dependable pillar of the proptech industry. With investors pouring capital into AI‑powered forecasting, security, automation, and property management tools, the sector is shifting from experimentation to full‑scale adoption. Brokerages, developers, and institutional players now rely on AI to streamline due diligence, enhance market modeling, reduce risk, and optimize building operations. As adoption accelerates, professionals who understand and leverage these technologies are gaining a decisive competitive edge in fast‑moving markets like Florida.
A new episode of Current Account breaks down why the insurance industry is heading into 2026 with more uncertainty — and more opportunity — than ever. From shifting global regulations and rising catastrophe risks to FSOC’s evolving role in the U.S., industry leaders Jérôme Haegeli and Philippe Brahin explain how insurers are being pushed to rethink strategy in real time. With global premium growth expected to slow and regulatory pressures rising, professionals in insurance and financial services are turning to education and new skills to stay ahead in a rapidly changing market.
New Jersey is quietly becoming one of the hottest commercial real estate markets in the nation, with Jersey City and North Jersey breaking into the top 10 in PwC’s 2026 Emerging Trends report. Fueled by redevelopment momentum, data‑center demand, mixed‑use transformations and a surge in health‑care projects, the state is drawing major investors while still battling rising construction costs and municipal fatigue. For real estate professionals, the Garden State’s evolution signals fresh opportunity—and a market worth watching closely heading into 2026.
The National Council of Insurance Legislators is pushing back against President Trump’s new executive order on artificial intelligence, arguing that it threatens decades of state‑based insurance oversight. NCOIL leaders say federal attempts to centralize AI authority could disrupt markets, weaken consumer protections, and limit states’ ability to innovate—setting the stage for a significant legal and political battle with major implications for insurance professionals who rely on AI‑driven tools and regulatory clarity.
